SolaVAX uses UV light and Vitamin B2 to inactivate viruses while preserving their immune-stimulating components

“We identified influenza as a top priority given the need for improved vaccines,” stated Dr. Michael Artinger, CEO of Solaris. “It is a perfect opportunity to demonstrate the unique attributes of SolaVAX and directly address the inherent problems of current methods.”

FORT COLLINS, Colo. (PRWEB)
June 21, 2023

Solaris Vaccines, Inc. announced today that it has received a Small Business Innovative Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) to create an improved influenza (flu) vaccine. Each year, influenza causes significant disease and death worldwide. Current vaccines typically only provide 40% to 60% protection—and in some years, as little as 10%—and suffer from outdated manufacturing approaches. For example, the majority of flu vaccines produced today use fertilized chicken eggs, a labor-intensive method that can result in a suboptimal product.

SolaVAX™ is a new paradigm using UV light and Vitamin B2 to inactivate viruses while preserving their immune-stimulating components. The result is a faster, cost-effective means of creating more-protective and safer vaccines. This approach can be applied to any pathogen, including not only other viruses beyond influenza, but to prevent diseases caused by bacterial, parasitic and fungal agents as well.

“We identified influenza as a top priority given the need for improved vaccines,” stated Dr. Michael Artinger, CEO of Solaris. “It is a perfect opportunity to demonstrate the unique attributes of SolaVAX and directly address the inherent problems of current methods.”

In preliminary in vitro and in vivo studies, a SolaVAX-generated flu vaccine provided 100% retention of hemagglutinin (HA) activity compared with only 50% using traditional formalin. The Phase I project will establish the inactivation process and the efficacy of the vaccine produced with the SolaVAX method. Addressing the ability of the SolaVAX technology platform to produce a protective and logistically straightforward influenza vaccine will greatly enhance the value of SolaVAX as a production method for new vaccine candidates for both existing and emerging disease threats. In addition to flu, SolaVAX is being used to create vaccines for SARS-CoV-2, tuberculosis and other infectious diseases, further validating it as a manufacturing platform with nearly limitless versatility.

About Solaris Vaccines, Inc.

Solaris Vaccines, Inc. was formed 2021 to address many of the challenges of creating vaccines in response to emerging threats to global human health. Current methods of developing and manufacturing vaccines are slow, not fully protective, technically complex, use toxic chemicals, and often have onerous storage requirements. The Solaris SolaVAX™ method uses riboflavin (vitamin B2) and UV light to rapidly and effectively inactivate pathogens, resulting in a new approach for creating vaccines against pathogens such as viruses, bacteria and parasites. Go to https://solarisvax.com/ to learn more.

Share article on social media or email:

Leaders from Mary Washington Healthcare will speak at the Healthcare Financial Management Association (HFMA)’s 2023 Annual Conference on Monday, June 26, 2023, in Nashville, Tenn.

“We’re excited to discuss Mary Washington Healthcare’s success pursuing an innovative mindset and leveraging new AI-based technologies.” – Abigail Armstead, Technical Product Manager for Medical Informatics at MCG Health

NASHVILLE, Tenn. (PRWEB)
June 21, 2023

MCG Health, part of the Hearst Health network and an industry leader in technology-enabled, evidence-based guidance, announces its Technical Product Manager for Medical Informatics, Abigail Armstead, will host experts from Mary Washington Healthcare at the Healthcare Financial Management Association (HFMA)’s 2023 Annual Conference. The HFMA conference runs June 25-28, 2023, and will take place at the Gaylord Opryland in Nashville, Tennessee.

The session, “Finding Financial Predictability using AI in an Industry that is Anything but Predictable,” is part of the Innovation & Technology spotlight and will take place on Monday, June 26, 2023, from 9:50 am to 10:40 am Central Time. Ms. Armstead will host four thought leaders from Mary Washington Healthcare: Sarah Ogle, Senior VP of Revenue Cycle; Mary Loyd, Manager of Service Coordination and Performance Improvement; Cheri Basso, Director of Care Coordination; and Kimberly Mitkowski, Manager of Care Coordination.

The session will explore current challenges hospitals face in optimizing patient throughput, maintaining patient satisfaction, and maximizing appropriate revenue while minimizing their cost burdens. Mary Washington Healthcare, a recent recipient of the Richard L. Doyle Award for Innovation and Leadership in Healthcare, will share how they successfully navigated these obstacles to reduce denials, improve hospital throughput, and apply unique AI technologies (including MCG Indicia for Admission Documentation) to optimize their utilization review workflow. Attendees can expect to learn about the use of artificial intelligence (AI) to streamline clinical, financial, and operational aspects of the patient’s care journey into one experience. The speakers will also discuss valuable insights for process improvement, cost containment, and useful tactics to manage labor shortages and economic factors without sacrificing innovation.

“We’re excited to discuss Mary Washington Healthcare’s success pursuing an innovative mindset and leveraging new AI-based technologies,” said Ms. Armstead. “We’re hopeful that the insights we share in this session will help other hospitals facing these same industry challenges find a path forward for their communities.”

More information about the HFMA Annual Conference is available here: https://events.hfma.org/event/e5c80b52-e34d-4e45-9761-d353672c6b71/summary

Share article on social media or email:

Smileyscope devices being used.

MIAMI (PRWEB)
June 21, 2023

Nicklaus Children’s Hospital has implemented use of Australia- and Texas-based Smileyscope Holding Inc’s (Smileyscope™) state-of-the-art virtual reality (VR) therapeutics to soothe children during needle procedures in the hospital’s Emergency Department. Nicklaus Children’s is among the first children’s hospitals in the nation and the first in South Florida to offer this child-friendly, immersive technology.

“Needle procedures can be very stressful for children of all ages,” said Dr. David Seo, senior vice president and chief information and digital officer for Nicklaus Children’s Health System. “The Smileyscope virtual reality tool supports our Emergency Department clinicians in providing the artful distraction that is so beneficial to children during such procedures. Families can request VR support to reduce their child’s discomfort and anxiety.”

Evelyn Chan, CEO of Smileyscope, said, “We are extremely pleased to partner with Nicklaus Children’s Hospital to bring Smileyscope to South Florida. Nicklaus Children’s commitment to ensuring every child receives the best possible care and a comfortable experience is evident in their adoption of our device.”

One of the most requested VR experiences sought by children is the underwater adventure, which features waves washing over the injection site and a fish nibbling on the child’s arm during the injection. Clinical trials have shown this VR program can safely and effectively reduce pediatric needle pain by up to 60 percent and anxiety by 40 percent, allowing for a more comfortable and positive patient experience.

Giovanna Pedemonte of Miami brought her 7-year-old son, Silas, to the emergency department at Nicklaus Children’s with a high fever and an infection in his finger. “Silas typically gets anxious whenever he enters a clinical setting and asks whether he will be getting a shot or undergoing any pain,” said Pedemonte. “I was impressed to learn that Nicklaus Children’s offered the Smileyscope technology to distract him. He didn’t seem to notice the draining of the wound on his finger. He likes video games, and he enjoyed the technology so much that we will request Smileyscope whenever he visits the hospital,” she added.

To learn more about Nicklaus Children’s Hospital, visit http://www.nicklauschildrens.org and Smileyscope, visit http://www.smileyscope.com.

About Nicklaus Children’s Hospital

Founded in 1950 by Variety Clubs International, Nicklaus Children’s Hospital is South Florida’s only licensed specialty hospital exclusively for children. The hospital has about 800 attending physicians, including over 500 pediatric subspecialists. The 309-bed medical facility, known as Miami Children’s Hospital from 1983 through 2014, is renowned for excellence in all aspects of pediatric medicine with many specialty programs routinely ranked among the best in the nation by U.S. News & World Report since 2008. The hospital is also home to the largest pediatric teaching program in the southeastern United States and since 2003 has been designated an American Nurses Credentialing Center (ANCC) Magnet facility, the nursing profession’s most prestigious institutional honor. For more information, please visit http://www.nicklauschildrens.org.

About Smileyscope:

Smileyscope is a multi-award winning digital therapeutics company with proprietary technology that reframes medical procedures using choreographed virtual-reality (VR) experiences to help reduce patient pain and anxiety, and improve the overall patient experience. Smileyscope VR is the first regulatory body approved VR product for medical use and is clinically proven to reduce patient pain, anxiety and the need for restraints. The device is utilized by clinicians across a range of medical procedures such as vaccines, bloodwork, wound dressings, aesthetic inductions, nitrous oxide, and plaster cast applications/removals. Smileyscope VR has partnered with over 40 US hospitals to implement the VR technology.

Share article on social media or email:

University Hospitals Ahuja Medical Center Phase 2 project exceeded the project’s diversity, equity, and inclusion goals

“We understand that decisions we make today will open new doors of opportunity tomorrow for minority- and women-owned businesses, as well as for veteran-owned and small businesses,” said Kyle Merrill, Gilbane’s senior business leader in Cleveland.

BEACHWOOD, Ohio (PRWEB)
June 21, 2023

Gilbane Building Company, together with Regency Construction Services, Inc., Next Generation Construction, and Adrian Maldonado & Associates, Inc. (AMAINC), today announced that the University Hospitals Ahuja Medical Center Phase 2 project exceeded the project’s diversity, equity, and inclusion goals.

“We understand that decisions we make today will open new doors of opportunity tomorrow for minority- and women-owned businesses, as well as for veteran-owned and small businesses,” said Kyle Merrill, Gilbane’s senior business leader in Cleveland. “We take this responsibility seriously, not just in what we say, but in all the ways we advance diversity, equity, and inclusion at every level in the construction industry.”

The project, which celebrated its grand opening on June 9, 2023, not only adds a new Trauma Level 2 patient bed pavilion, a sports medicine building, and an expansion of health care services to the community, it also has prioritized using diverse and local suppliers on the landmark project.

The project exceeded all business and workforce diversity, equity, and inclusion goals, as reported by a third-party, minority- and female-owned consulting firm, The Euell Group. “Partnering with Gilbane on the UH Ahuja Phase 2 project was a win-win and a great experience for The Euell Group,” said President Veronica Cook-Euell. Project goals included contracting with diverse firms, including 15% minority business enterprise (MBE), 8% small business enterprise (CSBE), and 7% female business enterprise (FBE). MBE participation stands at 16.09%, CSBE is at 10.75%, and FBE is at 11.41%.

Similar successes were achieved in workforce participation goals. Cuyahoga County residents worked 46.73% of the hours on the project, more than double the 20% target. 17.71% of the hours worked on the project were performed by minority residents, besting the 15% goal; and women performed 5.95% of the hours worked on the project, beating a 5% goal.

“For more than a decade, UH has prioritized working with a diverse range of suppliers for construction projects,” said Percival Kane, Jr MHA, Chief Operating Officer, UH Ahuja Medical Center. “UH Ahuja Phase 2 continues these efforts.”

Three local, diverse firms were tapped to serve as associate construction management partners on this transformational project. Regency (Female-owned Business Enterprise), Next Generation (Minority-owned Business Enterprise), and AMAINC (Minority-owned Business Enterprise) provided staff in key project management roles, including superintendent, project manager, and project engineer. Their staff has been critical to the project’s success in meeting the planned completion date in June 2023.

“Our partners – Regency, Next Generation, and AMAINC – are a critical reason why this project stayed the course through significant challenges,” said Merrill. “Their leadership in field and management staff positions helped maintain the schedule and budget while ensuring safety was the highest priority. Gilbane is proud to work with diverse-owned and small businesses as our valued construction partners, and we look forward to continuing this path together on future projects throughout Cleveland.”

The University Hospitals Ahuja Medical Center Phase 2 has been more than just a healthcare project. It provided an opportunity for the three construction partners to grow in a hands-on fashion on a major project in the market.

“It has been a wonderful opportunity for our small family-owned business to have been a part of this unique healthcare project that allowed our staff to develop their management skills beyond bricks and mortars,” notes AMAINC’s President Adrian Maldonado. “We are truly grateful to Gilbane and University Hospitals for allowing us to learn and grow from this experience.”

Regency’s President, Tari Rivera, stated: “The partnership with University Hospitals, Sodexo, and Gilbane has had a positive impact on my firm. Working on a large hospital project like this helped us build capacity as a firm and provided an opportunity for our employees to grow.”

In addition to providing staff for professional services, Next Generation and AMAINC executed bid packages for the project that resulted in increasing capacity for the firms. Next Generation provided much of the enabling work, trailer work, doors, frames, and hardware; while AMAINC provided cleaning services for the trailer and sports medicine institute.

“Our partnership with University Hospitals and the Gilbane team was a huge success for Next Generation Construction,” said Next Generation’s President Shakorie Davis. “It was an anchor point project, showing us what we could do as partners and subcontractors. Next Generation self-performed our largest doors, frames, and hardware package to date. We were awarded a $3.6 million project and came in on time and within budget. This project allowed us to showcase what we can do with this scope of work and project size.”

About Regency Construction Services, Inc.

In the nearly three decades since our founding, Regency Construction Services, Inc., a Woman-Owned Business Enterprise (WBE), has completed hundreds of projects for public and private clients across Ohio. With offices in Brook Park and Columbus, our goal is to create environments that provide opportunity while ensuring quality, building trust, and fostering relationships — both for our clients and our team. Regency serves the commercial, healthcare, higher education, PK–12, library, nonprofit, park, and civic markets by specializing in Construction Manager at Risk, Design- Build, General Contracting, and Owner’s Representation services. We also offer standalone estimating and scheduling services, and we self-perform rough and finish carpentry scopes of work. What started as a three-person firm in 1994, has grown to a team of a diverse group of nearly 80 professionals, carpenters, and laborers. Learn more at: http://www.regencycsi.com.

About Next Generation Construction

Next Generation Construction (Next Gen) supplies a robust roster of construction services in the Greater Cleveland and Columbus, Ohio markets. Founded in 2009, Next Gen is a multi-faceted, minority-owned business, established to provide carpentry, laborer, and general contractor services initially, and growing into plumbing, metal stud framing, acoustical ceilings, hardware, development, and consulting support services over the last fourteen years. Next Gen strives to build an inclusive and diverse group of construction professionals and has become one of the leading minority-owned construction companies in the Northeastern Ohio market, with over $30 million in revenue annually. For more information, visit http://www.nxtgc.com.

About Adrian Maldonado & Associates, Inc.

Adrian Maldonado & Associates, Inc. (AMAINC) was started in 2007 as a small post-construction clean-up operation and provided consulting services for diversity and inclusion reporting for various clients in the government sector. Over the last 10 years, the company has evolved into providing highly trained and qualified project engineers, safety officers, and superintendents on some of Northeast Ohio’s largest projects. In addition, AMAINC is a trusted partner in providing preconstruction and associate construction management Services. AMAINC has a diverse staff which is bi-lingual as well. AMAINC is a signatory company. More information can be found at http://www.adrianmaldonadoandassociates.org.

About The Euell Group

The Euell Group is a full-service strategic supplier diversity education and consulting firm with expertise in construction outreach, engagement, community liaison, and minority business development, reporting, and monitoring. Professional services in the area of diversity and inclusion training, as well as drug-free safety programs and training, are also our specialties. We are committed to our clients, their business strategies and delivering excellence in partnering on short-list presentations and representation at the highest caliber to bring home the contract. Learn more at http://www.theeuellgroup.com/.

About Gilbane Building Company

Gilbane provides a full slate of construction and facilities-related services – from preconstruction planning and integrated consulting capabilities to comprehensive construction management, general contracting, design-build, and facility management services – for clients across various markets. Founded in 1870 and still a privately held, family-owned company, Gilbane has more than 45 office locations worldwide. Gilbane is one of the most established and leading construction managers in the Northeast Ohio market and averages more than $500 million in revenue in the state annually. For more information, visit http://www.gilbaneco.com.

“We have been searching for a reputable business partner that can help us continue along our growth trajectory. We couldn’t be more excited to partner with Elite Physical Therapy with their reputation for superior customer service and quality care.” – Mark Hart, PT of Tri-State

ALEXANDRIA, La. (PRWEB)
June 21, 2023

Elite Physical Therapy (ELITE) is proud to announce its latest partnership with Tri-State Physical Therapy (Tri-State), a therapist-owned physical therapy practice located in both Shreveport and Bossier City, Louisiana. The partnership is an exciting opportunity for both companies to expand their reach and provide comprehensive care to patients across a larger region.

“We have been searching for a reputable business partner that can help us continue along this growth trajectory,” said Mark Hart, PT of Tri-State. “And for these reasons we couldn’t be more excited to partner with Elite Physical Therapy. Their established practice, with a reputation for superior customer service and quality care, is the perfect fit for us. We are truly thankful for Dan Turner and his forty-five years of leadership at Tri-State, and now look forward to what our new partnership will bring!”

Tri-State patients will continue to receive the same high-quality care from the same familiar faces they know and trust. However, the clinical team will now have access to ELITE’s parent company, Confluent Health, and their established ecosystem of management services as well as education and musculoskeletal health resources. Support services include efficient community outreach, digital innovations, value-based care pathway models, and marketing and finance tools. Resources include best in brand physical therapy partnerships, such as the PTPN network, continuing education programs and staff development opportunities with Evidence in Motion, a nationally recognized residency, fellowship, and certification education provider in physical and occupational therapy programs and Fit For Work, the leading provider of employee safety.

“Since opening our doors, our vision has been to provide the highest level of service to our patients and referring physicians throughout all of our clinics and across the state of Louisiana,” said Don Cassano, Jr., MPT, DPT, OCS, CEO of ELITE. “We are delighted that this partnership will allow us to continue this vision and reach more residents than before.”

This partnership will further expand ELITE’s footprint, making it the proud owner of four clinics across Louisiana. Confluent Health’s President and CEO, Larry Benz, PT, DPT, OCS, MBA, MAPP, states, “We are proud to partner with ELITE and are excited to welcome Tri-State into the Confluent Health family. Don’s team is made up of pre-eminent clinical leaders, and bringing in Tri-State is going to add significant value as we grow together. Our partnership has endless possibilities.”

For more information about ELITE, visit their website at eliteptla.com. To schedule an appointment with one of Tri-State’s expert therapists, visit their website at tristatept.com or call 318-746-5295.

###

About Elite Physical Therapy: Elite Physical Therapy (ELITE) is a Louisiana-based, private physical therapy practice group. As a proud member of the Confluent Health family, EPT positively impacts patients’ lives by delivering the best care and results through proven research, innovative treatments and technologies, and an approach that treats patients like family. For more information, visit eliteptla.com, or find them on Facebook at @elitephysicaltherapyalexandria.

About Confluent Health: Confluent Health is a family of physical and occupational therapy companies. We are transforming healthcare by strengthening private practices, developing highly effective clinicians, innovating new services and technology to improve the quality of care for patients, and lowering costs via more effective treatment, workplace wellness, and injury prevention. For more information, visit goconfluent.com or find us on Facebook at @confluenthealth.

Share article on social media or email:

National Leader for Children’s Orthopedics

“We take immense pride in the exceptional outcomes achieved by our orthopedics team and acknowledge that our continued inclusion in this prestigious list is a testament to the unwavering dedication of our entire staff,” said Caitlin Stella, MPH, CEO of Joe DiMaggio Children’s Hospital.

HOLLYWOOD, Fla. (PRWEB)
June 21, 2023

Joe DiMaggio Children’s Hospital has once again achieved national recognition for its excellence in orthopedics, earning a coveted spot among the top 50 children’s hospitals in the country. This prestigious accolade comes from U.S. News & World Report, the esteemed authority in hospital rankings and consumer advice. For nine consecutive years, Joe DiMaggio Children’s Hospital‘s Orthopedic Center has consistently received this national recognition.

“When it comes to the well-being of your child, where you go truly matters. At Joe DiMaggio Children’s Hospital, we understand the gravity of those crucial moments. That’s why we are proud to have a team of distinguished experts in pediatric orthopedics, ready to provide the highest level of care,” said Caitlin Stella, MPH, Chief Executive Officer of Joe DiMaggio Children’s Hospital. “Our continued inclusion in this prestigious list is a testament to the unwavering dedication and commitment of our entire staff. We take immense pride in the exceptional outcomes achieved by our orthopedics team. However, it is the collective commitment of our entire hospital to deliver unparalleled care for children that we truly celebrate.”

This recognition reflects Joe DiMaggio Children’s Hospital diverse and innovative medical expertise. Joe DiMaggio Children’s Hospital Orthopedic Center has one of the largest groups of fellowship trained pediatric orthopedic surgeons in Florida, and one of the busiest in the country, providing world class care and expertise for a variety of musculoskeletal conditions and sports-related injuries affecting children, adolescents and young adults.

U.S. News, together with RTI International, a North Carolina-based research and consulting firm, collected and analyzed data from 119 children’s hospitals and surveyed thousands of pediatric specialists. Children’s hospitals awarded a “Best” designation excelled at factors such as clinical outcomes, level and quality of hospital resources directly related to patient care and expert opinion among pediatric specialists.

“For 17 years, U.S. News has provided comprehensive information to help parents of sick children and their doctors find the best children’s hospital to treat their illness or condition,” said Ben Harder, chief of health analysis and managing editor at U.S. News.

For more information on the U.S. News Best Children’s Hospitals, explore Facebook, Twitter and Instagram using #BestHospitals.

Joe DiMaggio Children’s Hospital Orthopedic Center has several office locations throughout Broward and Palm Beach counties. Call 954-265-6300 or visit JDCH.com/orthopedics for a second opinion or to schedule an appointment.

###

About Joe DiMaggio Children’s Hospital

Joe DiMaggio Children’s Hospital is one of Florida’s leading pediatric hospitals, offering a comprehensive scope of healthcare services and programs in a caring, compassionate setting designed specifically for children. A level one pediatric trauma center, the hospital, part of Memorial Healthcare System, combines advanced technology and the expertise of one of the largest and most diverse, groups of board-certified pediatric specialists in the region, with a focus on patient and family-centered care to heal the body, mind, and spirit. To learn more, visit jdch.com and connect with @jdchospital on Facebook, Twitter, YouTube and Instagram.

About U.S. News & World Report

U.S. News & World Report is the global leader in quality rankings that empower consumers, business leaders and policy officials to make better, more informed decisions about important issues affecting their lives and communities. A multifaceted digital media company with Education, Health, Money, Travel, Cars, News, Real Estate, Careers and 360 Reviews platforms, U.S. News provides rankings, independent reporting, data journalism, consumer advice and U.S. News Live events. More than 40 million people visit USNews.com each month for research and guidance. Founded in 1933, U.S. News is headquartered in Washington, D.C.

Share article on social media or email:

“Macro’s patient centric model and generation of net-new data will improve the R&D landscape so that safer, better drugs will become more accessible.”

LOS ANGELES (PRWEB)
June 21, 2023

Macro Trials, a new precision research clinical platform, launched today to transform clinical trials. The company’s founders incubated Macro Trials with INITIATE Studios, a venture studio that co-creates companies at the intersection of healthcare, life sciences, and technology. As part of its launch, the company also announced $6 million in seed funding for ongoing product development, expanding its clinical trial infrastructure across geographies and therapeutic areas, and scaling its study execution and data generation flywheel as it fills an urgent market need. The round was led by MBX Capital and included participation from INITIATE Ventures, Healthy VC, Inflect Health, and Village Global, a venture firm backed by Jeff Bezos, Bill Gates, and Mark Zuckerberg.

“High-value therapeutics are the largest and fastest growing segment of pharmaceutical pipelines, but because clinical trials are fundamentally broken, many life-saving drugs will never make it to market. And those that do will cost far more than they should,” said Zeshan Muhammedi, Managing Partner of MBX Capital. “Macro’s patient centric model and generation of net-new data will improve the R&D landscape so that safer, better drugs will become more accessible.”

In 2021, there were a record-breaking 84 new drugs launched and another 20,000 in development. Although $212 billion was spent on R&D, success rates reached a record-low of 5%. These high failure rates continue to drive up the expense associated with bringing a new drug to market: it now costs approximately $2.7 billion to commercialize a high-value therapeutic, with 70% of that spend attributed to conducting clinical trials. Unfortunately, 80% of those trials fail to meet enrollment goals, and the challenges don’t end there. Even after a drug has been approved by the FDA, that drug may still fail to achieve its therapeutic target in the broader population, often due to significant under-representation of people of color, women, and older adults in the clinical trials that were conducted. Macro tackles these issues head on to bring rigorously tested, life-saving drugs to market faster and cheaper than ever before.

Via its digitally powered infrastructure, Macro works closely with pharmaceutical companies, CROs, physicians, and health systems to design, plan, and execute clinical trials for high-value therapeutics with increased research velocity. Through the aggregation and synthesis of proprietary real-world evidence (RWE), Macro generates an immensely valuable longitudinal patient record.

The Right Model for Equitable Access

Powered by a distributed “hub-and-spoke” model, Macro has conducted trials in all research settings – from in-person to decentralized. The company’s turnkey platform empowers physician groups and independent clinicians to participate in groundbreaking research via workflow-native efficiency tools, clinical research personnel, a network of logistic partners, and digital infrastructure for real-time data collection and management. By enabling patient recruitment at the site of care, Macro and its network of principal investigators lower the barrier to entry in clinical research by meeting patients where they are, driving a track record of equitable enrollment that reflects the diversity of the impacted population.

From even its earliest trials, Macro has proven that it truly unlocks increased diversity for results that map to real-world patient demographics for greater post-market success. For example, based on a recent representative study Macro enrolled >75% female trial participants compared to an industry standard of 41%; showed age disparity between trial participants and patients of less than one year, compared to the typical 7-10 years; and 46% of Macro’s trial participants were Hispanic-identifying, versus the typical 6% average Hispanic representation observed in clinical research.

“We are living through a golden age of therapeutics, but there are glaring gaps that make it challenging for breakthrough research to be brought to market,” said Iana Dimkova, CEO of Macro Trials. “Macro Trials is purpose-built to address these gaps with our patient-focused, end-to-end clinical research platform. Harnessing the latest technology advances, we believe we can amplify therapeutic value from one patient to millions, ultimately transforming care.”

To find out more about how the platform works, please visit https://www.macrotrials.com.

About Macro Trials

Macro Trials is the precision research clinical platform, driving increased research velocity and an amplified patient experience to unlock value for all stakeholders in the clinical trial ecosystem. Via its digitally powered infrastructure and “hub-and-spoke” distributed model, Macro partners with pharmaceutical companies, CROs, providers, and health systems to conduct trials for high-value therapeutics. The company’s turnkey platform empowers physicians to participate in groundbreaking research via workflow-native efficiency tools, clinical research personnel and a network of logistic partners. Macro’s clinical trial intelligence platform and proprietary real-world evidence as a service (RWEaaS) product supports life sciences companies in all aspects of therapeutic research, development, and commercialization. Learn more at http://www.macrotrials.com.

About MBX Capital

MBX Capital is a boutique venture capital firm that partners with and creates healthcare and biotechnology companies that are disrupting conventions in service to public health. MBX focuses primarily on early-stage companies that are inventing in overlooked domains of knowledge or which are harnessing edge effects to instigate quantum leaps in their fields. The firm was founded by Zeshan Muhammedi and Gurdane Bhutani in 2020. Learn more at mbxcapital.com.

About INITIATE

INITIATE is a company creation and investing platform that partners with exceptional entrepreneurs to create tomorrow’s breakthroughs and reshape the future of healthcare. INITIATE focuses on the intersection of healthcare, life sciences, and technology, including healthtech SaaS, diagnostics, life sciences tools, and biopharma platforms & services. Learn more about company creation at http://www.initiate.studio and early stage venture investing at http://www.initiate.vc

Share article on social media or email:

BDWKABS04-BK: a complete desk workstation set-up with a washable/waterproof keyboard (KBWKABS104-BK), mouse (OMWKABS04-BK), and repositionable mouse pad (MPWKR-1). Stay clean, stay productive!

Having a reliable and hygienic workstation is a must.

ATLANTA (PRWEB)
June 21, 2023

WetKeys Washable Keyboards, a premier provider of hygienic workstation solutions including waterproof computer peripherals and water-resistant keyboards, is delighted to launch the KBWKABS104-BK keyboard and the OMWKABS04-BK mouse. Combined with their unique, washable mouse pad, these groundbreaking products are pivotal for organizations seeking to establish rigorous hygiene measures as employees transition back into traditional office spaces.

Ensuring unmatched durability and user-friendly cleaning procedures, these WetKeys products not only help to prevent the spread of diseases but also cater to the rising employee demand for a safe, hygienic office environment. These peripherals are part of our lineup of water-resistant keyboards and rugged computer peripherals, designed to combine functionality, robustness, and simplified maintenance.

David Malo, the COO of WetKeys, underlined, “Having a reliable and hygienic workstation is a must. Our range of cleanable computer accessories, which includes the resilient SaniType keyboards, meets this requirement perfectly, standing up to even the toughest cleaning regimens. This significantly contributes to establishing a healthy and safe office environment.”

As companies strategize their transition back to the office, WetKeys Washable Keyboards delivers a feasible solution to support employee health and comfort. Our hygiene friendly office equipment, including durable and washable mice, helps businesses create a clean and secure work environment.

Ready to prioritize the health and wellbeing of your team? Don’t delay – upgrade your office workspace with WetKeys Washable Keyboards today! Visit our website or call us directly to learn more about our products and how they can provide a healthier and safer environment for your office. Embrace the future of hygienic workstations with WetKeys!

About WetKeys

WetKeys® Washable Keyboards was founded with a focus on function for industrial, institutional, food processing, and general use with easy-to-sanitize products. Later SaniType® Sanitary Typing created affordable, germ-resistant medical keyboards to help prevent cross-contamination, improving patient and staff safety in healthcare facilities and dental offices.

Today, they have over ten unique product lines and are home to the widest selection of sealed, washable computer keyboards and waterproof computer mice. WetKeys® Washable Keyboards is a graduate of the Advanced Technology Development Center of Georgia Tech, a certified Small Business Enterprise (SBE), and a Certified Diversity Supplier. They have been featured on CNBC, NBC’s Today Show, and Fox News. Learn more about WetKeys Washable Keyboards, here.

Share article on social media or email: